Methods for enhancing exposure therapy using pairing with vagus nerve stimulation

US10213577B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10213577-B2
Application numberUS-201514808509-A
CountryUS
Kind codeB2
Filing dateJul 24, 2015
Priority dateJul 2, 2008
Publication dateFeb 26, 2019
Grant dateFeb 26, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed is a method of enhancing exposure therapy comprising providing an exposure therapy to a patient and stimulating the patient's vagus nerve at the same time as the exposure therapy. Also disclosed is a post-traumatic stress disorder therapy method comprising providing an exposure event to a patient and stimulating the patient's vagus nerve during the exposure event. Also disclosed is a phobia disorder therapy method comprising providing an extinction event to a patient and stimulating the patient's vagus nerve during the exposure event. Also disclosed is an obsessive compulsive disorder therapy method comprising providing a therapy event to a patient and stimulating the patient's vagus nerve during the therapy event. Also disclosed is an addiction disorder therapy method comprising providing a therapy event to a patient and stimulating the patient's vagus nerve during the therapy event.

First claim

Opening claim text (preview).

The invention claimed is: 1. A post-traumatic stress disorder (PTSD) therapy method comprising: providing, to a patient, an exposure event which is sensory-recreative of a traumatic event that contributed to the PTSD; and electrically stimulating the patient's vagus nerve during the exposure event. 2. The method of claim 1 , wherein said therapy is a memory extinction therapy. 3. The method of claim 1 , wherein said patient's vagus nerve is stimulated using a voltage controlled capacitive discharge stimulation pulse. 4. The method of claim 1 , wherein said patient's vagus nerve is stimulated electrically with a stimulation intensity less than about 0.8 mA or about 0.8 mA. 5. The method of claim 1 , wherein said therapy is an addiction therapy. 6. The post-traumatic stress disorder therapy method of claim 1 , wherein said exposure event contains sensory recreations of a traumatic event. 7. The post-traumatic stress disorder therapy method of claim 1 , wherein said patient's vagus nerve is invasively stimulated electrically. 8. The method of claim 7 , wherein the action of providing the exposure event to the patient and the action of stimulating the patient's vagus nerve during the exposure event results in a reduction of the post-traumatic stress disorder of the patient. 9. The method of claim 1 , wherein the patient is a patient where the PTSD took months to develop following an initial exposure to a traumatic event that resulted in the PTSD. 10. The method of claim 1 , wherein the actions of providing exposure events and stimulating the patient's vagus nerve occur long after a traumatic event that resulted in the PTSD. 11. The method of claim 1 , wherein the actions of providing exposure events and stimulating the patient's vagus nerve are part of an extinction training regime, wherein the extinction training regime is commenced two weeks after induction of an initial fear conditioning. 12. The post-traumatic stress disorder therapy method of claim 11 , wherein said patient's vagus nerve is stimulated invasively utilizing an electrical current from a device. 13. The method of claim 1 , wherein the actions of providing exposure events and stimulating the patient's vagus nerve facilitate a natural extinction process of the patient that protects most people from developing post-traumatic stress disorder. 14. The method of claim 1 , wherein said therapy is a memory extinction therapy, the memory extinction therapy alleviating, at least in part, the post-traumatic stress disorder. 15. A phobia disorder therapy method comprising: providing, to a patient, an extinction event which is sensory-recreative of something that contributed to the phobia; and electrically stimulating the patient's vagus nerve during the extinction event, thereby at least partially alleviating the phobia disorder. 16. The method of claim 15 , further comprising: executing a retention test to determine a duration of an extinction of the phobia. 17. The phobia disorder therapy method of claim 15 , wherein said patient's vagus nerve is invasively stimulated electrically. 18. The method of claim 17 , wherein said patient's vagus nerve is stimulated using a constant current stimulation pulse. 19. The method of claim 17 , wherein said patient's vagus nerve is stimulated using a voltage controlled capacitive discharge stimulation pulse. 20. The method of claim 17 wherein a stimulation intensity is less than about 0.8 mA or about 0.8 mA. 21. The method of claim 17 , wherein a duration of the stimulation is about 100 ms to about 30 s. 22. The method of claim 17 , wherein a frequency of the stimulation is about 10 to about 150 Hz. 23. The method of claim 17 , wherein the action of providing the extinction event to the patient and the action of stimulating the patient's vagus nerve during the exposure event results in a reduction of the phobia disorder of the patient. 24. An obsessive-compulsive disorder (OCD) therapy method comprising: providing, to a patient, a therapy event which is sensory-recreative of something that contributed to the OCD; and electrically stimulating the patient's vagus nerve during the therapy event. 25. The obsessive-compulsive disorder therapy method of claim 24 , wherein the action of providing the therapy event entails providing an exposure event to the patient. 26. The method of claim 25 , wherein the action of providing the therapy event to the patient and the action of stimulating the patient's vagus nerve during the exposure event results in a reduction of obsessive-compulsive disorder. 27. The method of claim 24 , wherein said patient's vagus nerve is stimulated utilizing an electrical current from a device. 28. An addiction disorder therapy method comprising: providing, to a patient, a therapy event which is sensory-recreative of something that contributed to addiction-disorder; and electrically stimulating the patient's vagus nerve during the therapy event. 29. The addiction disorder therapy method of claim 28 , wherein the action of providing the therapy event entails providing an exposure event to the patient. 30. The method of claim 29 , wherein the action of providing the therapy event to the patient and the action of stimulating the patient's vagus nerve during the exposure event results in a reduction of the addiction disorder.

Assignees

Inventors

Classifications

  • Mood disorders, e.g. depression, anxiety or panic disorder · CPC title

  • Addiction or withdrawal from substance abuse such as alcohol or drugs · CPC title

  • Neuro-rehabilitation; Repair or reorganisation of neural tissue, e.g. after stroke · CPC title

  • for treating a mental or cerebral condition · CPC title

  • Mental training · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10213577B2 cover?
Disclosed is a method of enhancing exposure therapy comprising providing an exposure therapy to a patient and stimulating the patient's vagus nerve at the same time as the exposure therapy. Also disclosed is a post-traumatic stress disorder therapy method comprising providing an exposure event to a patient and stimulating the patient's vagus nerve during the exposure event. Also disclosed is a …
Who is the assignee on this patent?
Microtransponder Inc, Univ Texas
What technology area does this patent fall under?
Primary CPC classification A61M21/00. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).